{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:12:10Z","timestamp":1784545930964,"version":"3.55.0"},"reference-count":80,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.2967\/jnumed.120.243170","type":"journal-article","created":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T02:45:15Z","timestamp":1601693115000},"page":"304-312","source":"Crossref","is-referenced-by-count":47,"title":["The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders, Part 1: Hyperthyroidism"],"prefix":"10.2967","volume":"62","author":[{"given":"Giuliano","family":"Mariani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Tonacchera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Orsolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. William","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2020,10,2]]},"reference":[{"key":"2021030407200940000_62.3.304.1","doi-asserted-by":"publisher","DOI":"10.1093\/bmb\/ldr030"},{"key":"2021030407200940000_62.3.304.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2409"},{"key":"2021030407200940000_62.3.304.3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03520340064038"},{"key":"2021030407200940000_62.3.304.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.2.489"},{"key":"2021030407200940000_62.3.304.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb01894.x"},{"key":"2021030407200940000_62.3.304.6","doi-asserted-by":"publisher","DOI":"10.4158\/EP171796.RA"},{"key":"2021030407200940000_62.3.304.7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1530\/EJE-19-0666","article-title":"Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis","volume":"182","author":"van Hulsteijn","year":"2020","journal-title":"Eur J Endocrinol."},{"key":"2021030407200940000_62.3.304.8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1515\/bchm2.1896.21.4.319","article-title":"On the normal occurrence of iodine in the animal body [in German]","volume":"21","author":"Baumann","year":"1895","journal-title":"Hoppe Seylers Z Physiol Chem."},{"key":"2021030407200940000_62.3.304.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.12.4187"},{"key":"2021030407200940000_62.3.304.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(05)70306-6"},{"key":"2021030407200940000_62.3.304.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1991.tb00368.x"},{"key":"2021030407200940000_62.3.304.12","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12222"},{"key":"2021030407200940000_62.3.304.13","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-010-8245-8"},{"key":"2021030407200940000_62.3.304.14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-42-2-341"},{"key":"2021030407200940000_62.3.304.15","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1993.3.207"},{"key":"2021030407200940000_62.3.304.16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03121.x"},{"key":"2021030407200940000_62.3.304.17","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.2.492"},{"key":"2021030407200940000_62.3.304.18","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9896(2000)9999:9999<::AID-PATH650>3.0.CO;2-3"},{"key":"2021030407200940000_62.3.304.19","doi-asserted-by":"publisher","DOI":"10.1210\/me.9.6.725"},{"key":"2021030407200940000_62.3.304.20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1996.746567.x"},{"key":"2021030407200940000_62.3.304.21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2270"},{"key":"2021030407200940000_62.3.304.22","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0016"},{"key":"2021030407200940000_62.3.304.23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-1-4939-7902-8_9","article-title":"Thyroid hormones and derivatives: endogenous thyroid hormones and their targets","volume":"1801","author":"K\u00f6hrle","year":"2018","journal-title":"Methods Mol Biol."},{"key":"2021030407200940000_62.3.304.24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5694\/mja17.01204","article-title":"Thyroid nodules: diagnosis and management","volume":"209","author":"Wong","year":"2018","journal-title":"Med J Aust."},{"key":"2021030407200940000_62.3.304.25","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0348"},{"key":"2021030407200940000_62.3.304.26","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1007\/s00259-019-04472-8","article-title":"EANM practice guideline\/SNMMI procedure standard for RAIU and thyroid scintigraphy","volume":"46","author":"Giovanella","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.27","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1030"},{"key":"2021030407200940000_62.3.304.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.105148"},{"key":"2021030407200940000_62.3.304.29","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-013-2387-x"},{"key":"2021030407200940000_62.3.304.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000169204.13754.e2"},{"key":"2021030407200940000_62.3.304.31","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.779"},{"key":"2021030407200940000_62.3.304.32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1097\/MNM.0000000000000876","article-title":"Assessment of normal reference values for thyroid uptake of technetium-99m pertechnetate in a single centre UK population","volume":"39","author":"Macauley","year":"2018","journal-title":"Nucl Med Commun."},{"key":"2021030407200940000_62.3.304.33","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2010.0417"},{"key":"2021030407200940000_62.3.304.34","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229"},{"key":"2021030407200940000_62.3.304.35","doi-asserted-by":"publisher","DOI":"10.1159\/000490384"},{"key":"2021030407200940000_62.3.304.36","doi-asserted-by":"publisher","DOI":"10.1053\/nm.2000.4597"},{"key":"2021030407200940000_62.3.304.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.76.6.1516"},{"key":"2021030407200940000_62.3.304.38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-101-4-488","article-title":"Successful treatment of solitary toxic thyroid nodules with relatively low-dose iodine-131, with low prevalence of hypothyroidism","volume":"101","author":"Ross","year":"1984","journal-title":"Ann Intern Med."},{"key":"2021030407200940000_62.3.304.39","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.1999.00635.x"},{"key":"2021030407200940000_62.3.304.40","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1536-8"},{"key":"2021030407200940000_62.3.304.41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2016.0222","article-title":"Antithyroid drugs: the most common treatment for Graves\u2019 disease in the United States\u2014a nationwide population-based study","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid."},{"key":"2021030407200940000_62.3.304.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199206253262603"},{"key":"2021030407200940000_62.3.304.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801083380201"},{"key":"2021030407200940000_62.3.304.44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03279.x"},{"key":"2021030407200940000_62.3.304.45","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0450"},{"key":"2021030407200940000_62.3.304.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacr.2017.01.046"},{"key":"2021030407200940000_62.3.304.47","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1210\/jc.2015-1026","article-title":"Thiamazole pretreatment lowers the 131I activity needed to cure hyperthyroidism in patients with nodular goiter","volume":"100","author":"Kyrilli","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"key":"2021030407200940000_62.3.304.48","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.52.237"},{"key":"2021030407200940000_62.3.304.49","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.2.499"},{"key":"2021030407200940000_62.3.304.50","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760043486"},{"key":"2021030407200940000_62.3.304.51","first-page":"260","article-title":"Dosage determination with radioactive isotopes; practical considerations in therapy and protection","volume":"59","author":"Marinelli","year":"1948","journal-title":"Am J Roentgenol Radium Ther."},{"key":"2021030407200940000_62.3.304.52","doi-asserted-by":"publisher","DOI":"10.1007\/s002590100621"},{"key":"2021030407200940000_62.3.304.53","first-page":"71","article-title":"The effective half-life of 131I during the treatment of autonomous thyroid disease with radioiodine [in German]","volume":"30","author":"M\u00fcller","year":"1991","journal-title":"Nucl Med (Stuttg)."},{"key":"2021030407200940000_62.3.304.54","doi-asserted-by":"publisher","DOI":"10.1097\/MNM.0b013e328333d303"},{"key":"2021030407200940000_62.3.304.55","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/50\/9\/018"},{"key":"2021030407200940000_62.3.304.56","first-page":"496","article-title":"Personalization of radioiodine treatment for Graves\u2019 disease: a prospective, randomized study with a novel method for calculating the optimal 131I-iodide activity based on target reduction of thyroid mass","volume":"56","author":"Orsini","year":"2012","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2796.1995.tb01230.x","article-title":"Influence of compensated radioiodine therapy on thyroid volume and incidence of hypothyroidism in Graves\u2019 disease","volume":"238","author":"Nygaard","year":"1995","journal-title":"J Intern Med."},{"key":"2021030407200940000_62.3.304.58","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2011.04204.x"},{"key":"2021030407200940000_62.3.304.59","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-13-5-548"},{"key":"2021030407200940000_62.3.304.60","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00278-6"},{"key":"2021030407200940000_62.3.304.61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ultrasmedbio.2015.09.011","article-title":"The sonographic features of the thyroid gland after treatment with radioiodine therapy in patients with Graves\u2019 disease","volume":"42","author":"English","year":"2016","journal-title":"Ultrasound Med Biol."},{"key":"2021030407200940000_62.3.304.62","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF03350896","article-title":"Appearance of anti TSH-receptor antibodies and clinical Graves\u2019 disease after radioiodine therapy for hyperfunctioning thyroid adenoma","volume":"22","author":"Regalbuto","year":"1999","journal-title":"J Endocrinol Invest."},{"key":"2021030407200940000_62.3.304.63","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-07-0666"},{"key":"2021030407200940000_62.3.304.64","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050535"},{"key":"2021030407200940000_62.3.304.65","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2006.16.667"},{"key":"2021030407200940000_62.3.304.66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2015.09.001"},{"key":"2021030407200940000_62.3.304.67","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1089\/thy.2018.0129","article-title":"Effects of radioactive iodine therapy on ovarian reserve: a prospective pilot study","volume":"28","author":"Evranos","year":"2018","journal-title":"Thyroid."},{"key":"2021030407200940000_62.3.304.68","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/thy.2019.0560","article-title":"Long-term effects of radioiodine treatment on female fertility in survivors of childhood differentiated thyroid carcinoma","volume":"30","author":"Nies","year":"2020","journal-title":"Thyroid."},{"key":"2021030407200940000_62.3.304.69","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1997.130"},{"key":"2021030407200940000_62.3.304.70","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2011.12.019"},{"key":"2021030407200940000_62.3.304.71","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1089\/thy.2016.0655","article-title":"Second primary cancer in patients with differentiated thyroid cancer: does radioiodine play a role?","volume":"27","author":"Silva-Vieira","year":"2017","journal-title":"Thyroid."},{"key":"2021030407200940000_62.3.304.72","doi-asserted-by":"publisher","DOI":"10.1530\/eje.1.02300"},{"key":"2021030407200940000_62.3.304.73","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2007.0171"},{"key":"2021030407200940000_62.3.304.74","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jamainternmed.2019.0981","article-title":"Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism","volume":"179","author":"Kitahara","year":"2019","journal-title":"JAMA Intern Med."},{"key":"2021030407200940000_62.3.304.75","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00259-019-04470-w","article-title":"Use of radioactive iodine treatment in patients with hyperthyroidism? A case for shared decision making","volume":"46","author":"Struja","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.76","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1007\/s00259-019-04476-4","article-title":"Use of radioactive iodine treatment in patients with hyperthyroidism: a case for shared decision making","volume":"46","author":"Giovanella","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.77","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s00259-019-04522-1","article-title":"Regarding the manuscript entitled \u201cAssociation of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism.\u201d","volume":"46","author":"Zhang","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.78","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/cen.14136","article-title":"Joint statement from the Society for Endocrinology and the British Thyroid Association regarding \u201cassociation of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism.\u201d","volume":"92","author":"Taylor","year":"2020","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2021030407200940000_62.3.304.79","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1007\/s00259-020-04748-4","article-title":"\u201cQuid autem vides festucam in oculo fratris tui et trabemin oculo tuo non vide\u201d on the hyperthyroidism-induced mortality and antithyroid drug-induced side effects in the era of radioiodine fake news","volume":"47","author":"Giovanella","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2021030407200940000_62.3.304.80","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12688"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.120.243170","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T15:26:37Z","timestamp":1614871597000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.120.243170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,2]]},"references-count":80,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,3]]}},"alternative-id":["10.2967\/jnumed.120.243170"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.120.243170","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,2]]}}}